The FDA has approved Eylea HD (aflibercept) 8 mg to treat patients with macular edema following retinal vein occlusion (RVO) with dosing of up to every 8 weeks after an initial monthly dosing period.

Figure 1: Retinal cell types and their birth order. In this article, I consider possible models of cell fate determination in the retina that involve intrinsic and extrinsic determinants. I discuss ...

A wireless implant helped patients with severe macular degeneration regain usable vision. The results point toward a new ...

MIT engineers have designed a retinal implant for people who have lost their vision from retinitis pigmentosa or age-related macular degeneration, two of the leading causes of blindness. The retinal ...

Apellis Pharmaceuticals (NASDAQ:APLS) said early Thursday that a total of ten cases of retinal vasculitis have been confirmed with two more suspected among recipients of its eye medication Syfovre.

Myopia, or nearsightedness, is a common eye condition. More than 40% of Americans can't see clearly at a distance because their eye is longer than normal. Usually myopia doesn't cause any problems ...

Please provide your email address to receive an email when new articles are posted on . FORT LAUDERDALE, Fla. — The direct, indirect, and intangible costs due to neovascular age-related macular ...

Menlo Park resident Carmen Caricchio is on a quest to cure childhood inherited retinal diseases, a group of rare conditions that cause the degeneration of the retina and can lead to vision impairment ...

The FDA approved Eylea HD for the treatment of macular edema following retinal vein occlusion, according to a press ...